[Automated system for supporting medical decision-making in the treatment of patients with renal parenchyma neoplasms first experience of using the web-platform Sechenov.AI_nephro results of multicenter testing].

Q4 Medicine
Urologiia Pub Date : 2024-11-01
A Zholdubaev A, V Glybochko P, G Alyaev Yu, V Butnaru D, V Shpot E, M Chernenky M, M Chernenky I, N Fiev D, V Proskura A, V Konyshev A, S Sirota E, M Ismailov Kh, K Shurygina R, A Amrakhov S, A Izmailova A, P Sarkisyan I, Yu Suvorov A, N Pavlov V, R Kabirov I, F Urmantsev M, E Baykov D, F Itkulov A, M Khafizov M, F Gilmetdinov R, A Antipina A, N Rossolovsky A, A Durnov D, A Bobylev D, D Ivanov S
{"title":"[Automated system for supporting medical decision-making in the treatment of patients with renal parenchyma neoplasms first experience of using the web-platform Sechenov.AI_nephro results of multicenter testing].","authors":"A Zholdubaev A, V Glybochko P, G Alyaev Yu, V Butnaru D, V Shpot E, M Chernenky M, M Chernenky I, N Fiev D, V Proskura A, V Konyshev A, S Sirota E, M Ismailov Kh, K Shurygina R, A Amrakhov S, A Izmailova A, P Sarkisyan I, Yu Suvorov A, N Pavlov V, R Kabirov I, F Urmantsev M, E Baykov D, F Itkulov A, M Khafizov M, F Gilmetdinov R, A Antipina A, N Rossolovsky A, A Durnov D, A Bobylev D, D Ivanov S","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the automated medical decision support system \"Sechenov.AI_nephro\" in the treatment of patients with renal parenchymal tumors.</p><p><strong>Materials and methods: </strong>The beta version of the web-platform \"Sechenov.AI_nephro\" consists of a neural network based on MONAI (Medical open network for AI) and a web interface, with algorithms classified based on segmentation data in manual mode using the 3D modeling program \"Amira\". A total of 441 patients with renal parenchymal tumors were included in the multicenter prospective study. Testing was carried out over 12 months in 3 urological centers: 358 (81.2%) patients from I.M. Sechenov First Moscow State Medical University, Moscow; 73 (16.6%) patients from Bashkir State Medical University; and 10 (2.3%) patients from Saratov State Medical University named after V.I. Razumovsky. In all cases, contrast-enhanced computed tomography (CT) was performed preoperatively. DICOM (Digital Imaging and Communications in Medicine) data of each patient's CT was uploaded to the web-platform \"Sechenov.AI_nephro\" for automatic construction of a 3D model of the tumor. The work of the web-platform \"Sechenov.AI_nephro\" was evaluated based on a questionnaire completed by surgeons who performed the surgical intervention. The questionnaire consisted of 14 questions, with a scoring system from 1 to 10 points. It was divided into 3 main sections, including first for assessment of the quality of work of the web-platform \"Sechenov.AI_nephro\"; second for evaluation of the use of the 3D model in communication with the patient, for surgical planning and intraoperative navigation; and third for analysis of the choice of useful data display mode, errors in constructing the 3D model.</p><p><strong>Results: </strong>The questionnaire was completed in 253 (57.37% of 441) cases. The quality of 3D models was rated 7.8-9.4 points, and the use of the 3D model in communication with the patient, for surgical planning and intraoperative navigation was rated 7.8-9.4 points. The 3D models were constructed correctly in 70% of cases. The area of interest was the useful mode of 3D models display in surgical planning. Incorrectly constructed anatomical elements were veins in 25.5% and the tumor in 26.4% of cases, respectively.</p><p><strong>Conclusion: </strong>The automated medical decision support system in the treatment of patients with renal parenchymal tumors \"Sechenov.AI_nephro\" demonstrated satisfactory quality of 3D reconstruction of pathological process. 3D models allow for personalized determination of the surgical tactic for treating patients with renal tumors.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 5","pages":"12-22"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologiia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To evaluate the automated medical decision support system "Sechenov.AI_nephro" in the treatment of patients with renal parenchymal tumors.

Materials and methods: The beta version of the web-platform "Sechenov.AI_nephro" consists of a neural network based on MONAI (Medical open network for AI) and a web interface, with algorithms classified based on segmentation data in manual mode using the 3D modeling program "Amira". A total of 441 patients with renal parenchymal tumors were included in the multicenter prospective study. Testing was carried out over 12 months in 3 urological centers: 358 (81.2%) patients from I.M. Sechenov First Moscow State Medical University, Moscow; 73 (16.6%) patients from Bashkir State Medical University; and 10 (2.3%) patients from Saratov State Medical University named after V.I. Razumovsky. In all cases, contrast-enhanced computed tomography (CT) was performed preoperatively. DICOM (Digital Imaging and Communications in Medicine) data of each patient's CT was uploaded to the web-platform "Sechenov.AI_nephro" for automatic construction of a 3D model of the tumor. The work of the web-platform "Sechenov.AI_nephro" was evaluated based on a questionnaire completed by surgeons who performed the surgical intervention. The questionnaire consisted of 14 questions, with a scoring system from 1 to 10 points. It was divided into 3 main sections, including first for assessment of the quality of work of the web-platform "Sechenov.AI_nephro"; second for evaluation of the use of the 3D model in communication with the patient, for surgical planning and intraoperative navigation; and third for analysis of the choice of useful data display mode, errors in constructing the 3D model.

Results: The questionnaire was completed in 253 (57.37% of 441) cases. The quality of 3D models was rated 7.8-9.4 points, and the use of the 3D model in communication with the patient, for surgical planning and intraoperative navigation was rated 7.8-9.4 points. The 3D models were constructed correctly in 70% of cases. The area of interest was the useful mode of 3D models display in surgical planning. Incorrectly constructed anatomical elements were veins in 25.5% and the tumor in 26.4% of cases, respectively.

Conclusion: The automated medical decision support system in the treatment of patients with renal parenchymal tumors "Sechenov.AI_nephro" demonstrated satisfactory quality of 3D reconstruction of pathological process. 3D models allow for personalized determination of the surgical tactic for treating patients with renal tumors.

[肾实质肿瘤患者治疗医疗决策支持自动化系统多中心测试结果网络平台Sechenov.AI_nephro的首次使用经验]。
目的:评估自动化医疗决策支持系统 "Sechenov.AI_nephro "在肾实质肿瘤患者治疗中的应用:网络平台 "Sechenov.AI_nephro "的测试版由一个基于MONAI(人工智能医学开放网络)的神经网络和一个网络界面组成,其算法基于使用三维建模程序 "Amira "手动模式下的分割数据进行分类。这项多中心前瞻性研究共纳入了 441 名肾实质肿瘤患者。测试在 3 个泌尿外科中心进行,历时 12 个月:358例(81.2%)患者来自莫斯科 I.M. 谢切诺夫第一莫斯科国立医科大学;73例(16.6%)患者来自巴什基尔国立医科大学;10例(2.3%)患者来自萨拉托夫国立拉祖莫夫斯基医科大学。所有病例在术前都进行了对比增强计算机断层扫描(CT)。每位患者 CT 的 DICOM(医学数字成像和通信)数据都上传到网络平台 "Sechenov.AI_nephro",用于自动构建肿瘤的 3D 模型。网络平台 "Sechenov.AI_nephro "的工作根据实施手术干预的外科医生填写的问卷进行评估。问卷由 14 个问题组成,评分标准为 1 至 10 分。问卷分为三个主要部分,第一部分用于评估 "Sechenov.AI_nephro "网络平台的工作质量;第二部分用于评估三维模型在与患者交流、手术规划和术中导航中的使用情况;第三部分用于分析有用数据显示模式的选择、构建三维模型过程中的错误:有 253 个病例(占 441 个病例的 57.37%)完成了问卷调查。三维模型的质量评分为 7.8-9.4 分,三维模型在与患者沟通、手术规划和术中导航中的应用评分为 7.8-9.4 分。在 70% 的病例中,三维模型的构建是正确的。值得关注的是三维模型在手术规划中的实用显示模式。25.5%的病例中解剖元素构建不正确,26.4%的病例中肿瘤构建不正确:治疗肾实质肿瘤患者的自动化医疗决策支持系统 "Sechenov.AI_nephro "展示了令人满意的病理过程三维重建质量。三维模型有助于个性化确定治疗肾肿瘤患者的手术策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Urologiia
Urologiia Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
160
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信